- Home
- PEPG vs GPRK Comparison
PEPG vs GPRK Comparison
Compare PEPG & GPRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PEPG | GPRK |
|---|---|---|
| Founded | 2018 | 2002 |
| Country | United States | Colombia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 353.9M | 397.8M |
| IPO Year | 2022 | 2009 |
Fundamental Metrics
Financial Performance| Metric | PEPG | GPRK |
|---|---|---|
| Price | $4.89 | $9.23 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | ★ $11.67 | $8.50 |
| AVG Volume (30 Days) | 683.6K | ★ 1.3M |
| Earning Date | 03-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.27% |
| EPS Growth | ★ 25.61 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $39.45 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.70 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.89 | $5.66 |
| 52 Week High | $7.80 | $10.34 |
Technical Indicators
Market Signals| Indicator | PEPG | GPRK |
|---|---|---|
| Relative Strength Index (RSI) | 41.17 | 53.94 |
| Support Level | $4.24 | $7.84 |
| Resistance Level | $5.50 | $10.34 |
| Average True Range (ATR) | 0.42 | 0.41 |
| MACD | -0.10 | -0.00 |
| Stochastic Oscillator | 18.64 | 47.03 |
Price Performance
Historical ComparisonAbout PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.
About GPRK Geopark Ltd
GeoPark Ltd is a Latin American oil and gas exploration and production company with assets in Colombia, Ecuador, Chile, Brazil, and Argentina. The company generates revenue from the sale of crude oil, condensate, and natural gas, net of value-added tax and discounts related to the sale and overriding royalties due to the ex-owners of oil and gas properties where the royalty arrangements represent a retained working interest in the property.